Orserdu
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Orserdu, covering 2023-01-27 to 2026-08-04. Get the full timeline:
Most recent: EMA Authorised: Orserdu (elacestrant) — Stemline Therapeutics B.V.
6 regulatory and trial events tracked for Orserdu, covering 2023-01-27 to 2026-08-04. Get the full timeline:
Most recent: EMA Authorised: Orserdu (elacestrant) — Stemline Therapeutics B.V.